Skip to main content
SCYX
NASDAQ Life Sciences

BARDA Awards SCYNEXIS Up to $214M Non-Dilutive Funding for SCY-247 Antifungal

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$6.462
Mkt Cap
$43.679M
52W Low
$3.53
52W High
$9.12
52W Position info
83% above low
Off High info
29% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

SCYX sits 83% above its 52-week low of $3.53 on light trading volume (0.2× avg).

Summary

SCYNEXIS secured a BARDA contract worth up to $214 million in non-dilutive funding to advance SCY-247, its second-generation antifungal, through NDA submission for two indications. The initial base period provides $18.5 million to move oral and IV formulations into a Phase 2 trial for invasive candidiasis. This is a major validation from a government agency and significantly de-risks the SCY-247 program without shareholder dilution. The company's cash runway into 2029 remains unchanged, and SCY-770 development continues as planned. The contract may extend up to 10 years, providing long-term funding visibility.

Updates

  1. · SEC 8-K — The 8-K states the BARDA contract was entered into on September 25, 2026, and includes contract number 75A50126C00007.

At the time of this announcement, SCYX was trading at $6.46 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $43.7M. The 52-week trading range was $3.53 to $9.12. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

SCYX - Latest Insights

SCYX
Nov 05, 2026, 8:01 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $3.84
Real-time Price: $3.21 info
Change: -$0.630 (-16%) info
Market Cap: $31.95M info
SCYX
Oct 06, 2026, 7:53 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $5.18
Real-time Price: $3.21 info
Change: -$1.97 (-38%) info
Market Cap: $31.95M info
SCYX
Sep 28, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.71
Real-time Price: $3.21 info
Change: -$1.50 (-32%) info
Market Cap: $31.95M info
SCYX
Aug 10, 2026, 4:30 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $5.27
Real-time Price: $3.21 info
Change: -$2.06 (-39%) info
Market Cap: $31.95M info
SCYX
Aug 10, 2026, 4:01 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $5.16
Real-time Price: $3.21 info
Change: -$1.95 (-38%) info
Market Cap: $31.95M info